Market Herald logo


Be the first with the news that moves the market

Cannara Biotech (TSXV:LOVE) has entered British Columbia’s marketplace and has launched its first two premium products in the vape and accessory categories.

Cannara’s President and Chief Executive Officer, Zohar Krivorot, stated that the BC Liquor Distribution Branch has shown great confidence in the company’s value proposition by listing seven SKUs across Tribal, Nugz, and Orchid CBD.

Source: Cannara Biotech Inc.

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Top Story: TransCanna (CSE:TCAN) commences Phase 2 construction at its Daly Facility

2 | Nextleaf (CSE:OILS) launches new cannabis brand, High Plains

3 | The Gummy Project (CSE:GUMY) expands in U.S. after receiving purchase order from a 5-star luxury hotel
4 | Global Hemp Group (CSE:GHG) & Revitalize Earth update reverse-takeover transaction

5 | Juva Life (CSE:JUVA) introduces Flōs, a new branded cannabis flower product line

Top Cannabis Stocks Sept 16 to Sept 22, 2022

1. T.HEXO | 7,853 views | HEXO Corp.
2. T.WEED | 7,101 views | Canopy Growth Corp.
3. TLRY  | 4,248 views | Tilray Brands Inc.
4. C.TNY| 3,276 views | Tinley Beverage Co. Inc.
5. V.LFST  | 2,316 views | Lifeist Wellness Inc.
6. T.ACB | 2,242 views | Aurora Cannabis Inc.

New to investing in Cannabis? Check out these tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit the Cannabis Bullboards page.

More From The Market Herald

" Silvercorp Metals Inc. Confirms Its Golden Potential with a Reserve and Resource Update

By Dr. Ryan D. Long

" No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Over the past two years, reporting on the Covid-19 pandemic has dominated media airwaves.
The Market Herald Video

" BioVaxys (CSE:BIOV) expands vaccines intellectual property portfolio

BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform.
Isracann Biosciences Inc. - CEO, Phil Floucault

" Isracann Bioscience (CSE:IPOT) facilitated genetics arrive in Israel

Isracann Bioscience (IPOT) announces that its first shipment of cannabis strains has cleared Israeli customs and are being raised as mother stock.